UK's RPSGB report calls for better Rx safety

23 February 2009

The Royal Pharmaceutical Society of Great Britain has published a report calling for action on medicines safety and launched a new award which  recognizes significant achievement in improving drug safety in the UK.  The report, The Contribution of Pharmacy to Making Britain a Safer Place  to Take Medicines, calls for a five to 10 year action plan to be drawn  up by pharmacists and other key health care providers to improve  prescription drug safety.

Nick Barber, one of the report authors and an RPSGB council member,  said: "medicines can offer great benefits, saving lives and improving  patients' ability to live full and active lives." Prof Barber added that  "we need to recognize that they can also have risks. If they are not  taken correctly, their effectiveness can be hampered or they can be  potentially harmful."

Patient safety is a concern for the National Health Service, with an  estimated cost for treating preventable harm from the adverse effects of  pharmaceutical products of GBP750.0 million ($1.07 billion) per year in  England alone.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight